Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed)
Grant Opportunity Analysis
The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) titled "Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed)." This initiative aims to identify innovative cure strategies for HIV that can be implemented at the initiation of combination antiretroviral therapy (cART) or upon restarting cART after treatment interruptions, with the ultimate goal of achieving sustained treatment-free remission. The program encourages interdisciplinary collaboration and participation from underrepresented groups, emphasizing the importance of advancing HIV cure research. Applications are due by December 7, 2023, and interested parties can find more information and guidelines at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries. The funding is contingent on NIH appropriations, and proposals will be evaluated based on scientific merit and potential impact.
Eligible Applicants
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.